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ABSTRACT
Glucose uptake occurs in skeletal muscle under basal conditions, and increases in response to 
stimuli such as insulin and exercise.  Exercise is known to increase blood flow, and it appears 
that insulin has similar hemodynamic effects, including increased blood flow and capillary 
recruitment, which can modify the amount of glucose uptake occurring under each condition.  
Here we study factors affecting both basal and stimulated myocyte glucose uptake, with a 
particular focus on vasoactive agents. 
Insulin stimulates the release of endothelin-1 (ET-1), a potent vasoconstrictor, from 
endothelial cells in culture. As yet it is unknown whether ET-1 is a type A (causing nutritive 
perfusion) or a type B (non-nutritive) vasoconstrictor, so here we use the pump-perfused rat 
hindlimb to characterize the distribution effects of ET-1.  We show that ET-1 causes a type A 
vasoconstriction, stimulating basal metabolism at low doses, while at high doses the 
distribution of flow changes to become non-nutritive, inhibitory to metabolism.  As a general 
vasodilator prevents both metabolic and hemodynamic effects, the effects on metabolism are 
due to the redistribution of flow.  These redistribution effects are confirmed by the ability of 
high dose ET-1 to decrease aerobic tension development in the contracting hindlimb, and by 
the ability of low dose ET-1 to increase the interstitial glucose concentration. 
Given this understanding of the effects of ET-1 alone, we can investigate the interactions 
between ET-1 and insulin.  In the perfused rat hindlimb, insulin has not been observed to have 
any vasodilatory effect, whereas here for the first time insulin appears to have vasodilator-like 
actions against ET-1 mediated vasoconstriction.  Also, the redistribution of flow by ET-1 does 
not appear to alter the metabolic effect of insulin to cause glucose uptake at either dose of ET-
1 used.   
Nitric Oxide (NO) is thought to be the mechanism by which insulin causes vasodilation in 
muscle.  A previous study has shown that methacholine (MC), by increasing NO, was able to 
augment insulin-mediated glucose uptake and capillary recruitment, while other NO donors 
were unable to do so.  Here we show that, at the dose used to increase glucose uptake in the 
previous study, MC has only a vasodilatory effect, and no direct effect on glucose uptake, in 
the perfused rat hindlimb.  At higher doses, an effect on glucose uptake can be observed.  This 
means that the increase in capillary recruitment by MC was responsible for the elevated 
insulin-mediated glucose uptake, and there was no direct effect of MC on glucose uptake.   
A recent publication suggested that the Na+-D-glucose cotransporter (SGLT1) was essential 
for insulin-mediated glucose uptake, although not required for basal glucose uptake.  The 
implications of this detract from our proposed role of blood flow redistribution in insulin 
action.  In attempting to reproduce these results in the perfused rat hindlimb we found that 
SGLT1 is not required for insulin-mediated glucose uptake, and confirmed this using a low 
sodium buffer, which would also inhibit the transporter.  We conclude that SGLT1 is not 
required for insulin-mediated glucose uptake. 
Our results therefore suggest that complex interactions are involved in insulin action, some of 
which involve hemodynamic actions that are capable of altering insulin-mediated glucose 
uptake, and others in which insulin itself can limit the action of other vasomodulators, such as 
ET-1.  It is apparent, however that SGLT1 in the endothelium may not be necessary for the 
metabolic effects of insulin, and that blood flow distribution, or capillary recruitment is 
therefore of great importance in delivering glucose to myocytes.  
vii
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